AzTrials
AzTrials

Intensive CareNutriSaveNCT01749488

The Impact of a Dietitian in the Implementation of Nutrition Recommendations During Intensive Care

A study testing Designated dietitian for the ward in people with Intensive Care, run by Centre Hospitalier Universitaire de Nīmes.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The main objective of this study is to evaluate the impact of the intervention of a dietician on the energy balance accumulated over seven days of intensive care. Energy balance is defined as the difference between the target recommended energy and total calorie intake actually received. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intensive Care
What is being tested?
Designated dietitian for the ward
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
Oct 2015to Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • The patient must be insured or beneficiary of a health insurance plan
  • Patients hospitalized in intensive care for an expected period greater than 72 hours, and for whom sufficient eating after 72 hours of hospitalization is deemed unlikely upon admission.
  • Patients receiving mechanical ventilation and having at least one organ failure other than respiratory failure, defined by a SOFA score greater than 2.

Who cannot join

  • The patient is under judicial protection
  • The patient (or his/her legal representative or "trusted-person") indicates they do not wish to participate in the study
  • It is impossible to correctly inform either the patient or his/her "trusted person"
  • The patient is participating in another study, or is in an exclusion period determined by another study
  • Moribund patients or those for whom death appears imminent (within 24 hours)
  • Survival to Day 28 unlikely due to uncontrollable comorbidities
  • Patients with advanced directives issued expressing the wish to not be resuscitated

About this study

Official title: The Impact of Involving a Dietitian in the Implementation of Expert Recommendations Concerning Nutrition During Intensive Care on Energy Balance

The main objective of this study is to evaluate the impact of the intervention of a dietician on the energy balance accumulated over seven days of intensive care.

Energy balance is defined as the difference between the target recommended energy and total calorie intake actually received.

This is a randomized-cluster study; participating centers are randomized into experimental and control groups.

Read the detailed description

The secondary objectives of this study are to compare the impact of the intervention of a dietician on:

  • daily and accumulated energy balance at the end of the intensive care unit (ICU) stay
  • deficits in protein intake per day, accumulated over 7 days, and accumulated for the ICU stay
  • intake of vitamins, trace elements and pharmaco-nutrients per day
  • predominant route of nutrition administration (enteral / parenteral / mixed)
  • the course of the stay: duration of mechanical ventilation, organ failure, the ICU stay, number of days on antibiotics
  • the presence / absence of complications: mortality, on catheter bacteremia, ventilator acquired pneumonia, other infections, bedsores, episodes of hyper-or hypoglycemia
  • presence/absence of diarrhea
  • costs related to the management of malnourished patients in terms of enteral and parenteral nutritional therapy, dietary supplements, antibiotics and sedatives as well as the costs of ICU stay and those related to diarrhea and sores
Conditions
Intensive Care
Being tested
Designated dietitian for the ward
Keywords
Dietitian, Nutritional recommendations, ICU nutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Designated dietitian for the wardOther

    This is a randomized cluster trial. The centers randomized into this arm will designate a dietitian who will help the ward implement current recommendations for the nutrition of patients undergoing intensive care.

Study groups in NCT01749488
Study groupRoleWhat they receive
Control intensive care wardsNo interventionThis is a randomized cluster trial. The centers randomized into this arm will serve as controls. No interventions will be implemented for these centers.
Experimental intensive care wardsExperimentalThis is a randomized cluster trial. The centers randomized into this arm will designate a dietitian who will help the ward implement current recommendations for the nutrition of patients undergoing intensive care. Intervention: Designated dietitian for the ward
Receives: Other: Designated dietitian for the ward

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caloric deficit accumulated over 7 days

    Caloric deficit accumulated over 7 days (kcal/kg)

    Measured: Day 7

Secondary outcomes (54)
  1. Average per day caloric deficit

    Average per day caloric deficit (kcal/kg/day)

    Measured: Day 7

  2. Caloric deficit accumulated during the ICU stay

    Caloric deficit accumulated during the ICU stay (kcal/kg)

    Measured: ICU discharge (maximum of 28 days)

  3. Average per-day protein deficit

    Average per-day protein deficit (grams protein/kg/day)

    Measured: Day 7

  4. Protein deficit accumulated over 7 days

    Protein deficit accumulated over 7 days (grams protein/kg)

    Measured: Day 7

  5. Protein deficit accumulated during the ICU stay

    Protein deficit accumulated during the ICU stay (grams protein/kg)

    Measured: ICU discharge (maximum of 28 days)

  6. Average per day amounts of vitamins received

    Measured: Day 7

  7. Average per day amounts of trace elements received

    Measured: Day 7

  8. Average per day amounts of pharmaco nutrients received

    Measured: Day 7

  9. Percentage of calories received by enteral route

    daily average

    Measured: Day 7

  10. Percentage of calories received by enteral route

    accumulated over 7 days

    Measured: Day 7

  11. Percentage of calories received by enteral route

    accumulated over ICU stay

    Measured: ICU discharge (maximum of 28 days)

  12. Percentage of proteins received by enteral route

    daily average

    Measured: Day 7

  13. Percentage of proteins received by enteral route

    accumulated over 7 days

    Measured: Day 7

  14. Percentage of proteins received by enteral route

    accumulated over ICU stay

    Measured: ICU discharge (maximum of 28 days)

  15. length of time spent on ventilator (hours)

    Measured: ICU discharge (maximum of 28 days)

  16. length of ICU stay (days)

    Measured: ICU discharge (maximum of 28 days)

  17. Number of days spent with (any) organ failure

    Measured: ICU discharge (maximum of 28 days)

  18. Number of days on antibiotics

    Measured: ICU discharge (maximum of 28 days)

  19. Mortality (yes/no)

    Measured: Day 90

  20. Mortality (yes/no)

    Measured: Day 180

  21. Presence/absence of on-catheter bacteremia

    Measured: Day 7

  22. Presence/absence of on-catheter bacteremia

    Measured: Day 28

  23. Presence/absence of on-catheter bacteremia

    Measured: ICU discharge (maximum of 28 days)

  24. Presence/absence of ventilator acquired pneumonia

    Measured: Day 7

  25. Presence/absence of ventilator acquired pneumonia

    Measured: Day 28

  26. Presence/absence of ventilator acquired pneumonia

    Measured: ICU discharge (maximum of 28 days)

  27. Presence/absence of other infections

    Measured: Day 7

  28. Presence/absence of other infections

    Measured: Day 28

  29. Presence/absence of other infections

    Measured: ICU discharge (maximum of 28 days)

  30. Presence/absence of bed sores

    Measured: Day 7

  31. Presence/absence of bed sores

    Measured: Day 28

  32. Presence/absence of bed sores

    Measured: ICU discharge (maximum of 28 days)

  33. Composite score for complications

    Presence/absence of at least one of the following complications: on-catheter bacteremia, ventilator acquired pneumonia, other infections, bed sores

    Measured: Day 7

  34. Composite score for complications

    Presence/absence of at least one of the following complications: on-catheter bacteremia, ventilator acquired pneumonia, other infections, bed sores

    Measured: Day 28

  35. Composite score for complications

    Presence/absence of at least one of the following complications: on-catheter bacteremia, ventilator acquired pneumonia, other infections, bed sores

    Measured: ICU discharge (maximum of 28 days)

  36. Minimum observed glycemia

    Measured: Day 7

  37. Minimum observed glycemia

    Measured: ICU discharge (maximum of 28 days)

  38. Maximum observed glycemia

    Measured: Day 7

  39. Maximum observed glycemia

    Measured: ICU discharge (maximum of 28 days)

  40. Average observed glycemia

    Measured: Day 7

  41. Average observed glycemia

    Measured: ICU discharge (maximum of 28 days)

  42. Presence/absence of a glycemia measure < 0.4 g/l

    Measured: Day 7

  43. Presence/absence of a glycemia measure < 0.4 g/l

    Measured: ICU discharge (maximum of 28 days)

  44. Presence/absence of a glycemia measure > 1.8 g/l

    Measured: Day 7

  45. Presence/absence of a glycemia measure > 1.8 g/l

    Measured: ICU discharge (maximum of 28 days)

  46. Presence/absence of hypertriglyceridemia

    Measured: Day 7

  47. Presence/absence of hypertriglyceridemia

    Measured: ICU discharge (maximum of 28 days)

  48. Accumulated cost of enteral nutrition

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

  49. Accumulated cost of parenteral nutrition

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

  50. Accumulated cost of antibiotics

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

  51. Accumulated cost of sedation

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

  52. Presence/absence of diarrhea

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

  53. Accumulated cost of nutritional supplements

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

  54. Accumulated cost of ICU stay

    Measured: Between Day 0 and ICU discharge (expected maximum of 28 days)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2012 (estimated)
  2. Study startOct 2015
  3. Primary completionOct 2017 (estimated)
  4. Study completionApr 2018 (estimated)

Why it stopped: The intervention becomes obsolete for participating centres pending regulatories.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01749488
Sponsor's protocol ID
PHRC-I/2012/SB-01
Other IDs
2012-A00626-37
Acronym
NutriSave
Status last verified
Aug 2016
First submitted
12 Dec 2012
Last updated
18 Jun 2026
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Designated dietitian for the ward in people with Intensive Care, run by Centre Hospitalier Universitaire de Nīmes.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 18 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caloric deficit accumulated over 7 days (time frame: Day 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in